Localized scleroderma in childhood: A report of 30 cases
Identifieur interne : 002C29 ( Main/Exploration ); précédent : 002C28; suivant : 002C30Localized scleroderma in childhood: A report of 30 cases
Auteurs : Yosef Uziel [Canada] ; Bernice R. Krafchik [Canada] ; Earl D. Silverman [Canada] ; Paul S. Thorner [Canada] ; Ronald M. Laxer [Canada]Source :
- Seminars in Arthritis and Rheumatism [ 0049-0172 ] ; 1994.
English descriptors
- Teeft :
- Achilles tendon, Acta derm venereol, Active phase, Anticentromere antibodies, Antihistone antibodies, Antinuclear antibodies, Arch dermatol, Arthritis rheum, Cerebral calcification, Clinical evaluation, Clinical study, Collagen, Collagen fibers, Convulsive disorders, Coup, Crest syndrome, Degranulated mast cells, Dermatol, Disease activity, Erythrocyte sedimentation rate, Family history, Fibroblast, Fibroblast proliferation, Fibrotic, Frontal lobe, Generalized morphea, Growth factor, Growth failure, Intravenous immunoglobulin, Intravenous methylprednisolone, Laboratory results, Lesion, Limited range, Linear sclcroderma, Linear scleroderma, Localized, Localized cutaneous scleroderma, Localized scleroderma, Many patients, Mast cell activation, Mast cell tryptase, Mast cells, Maxillary antrum, Medical history, Morphea, Mouse model, Muscle atrophy, Neurological symptoms, Nsaid, Pediatric, Pediatric series, Penicillamine, Pigmentary changes, Plastic surgery, Rare disease, Rheum, Rheumatoid factor, Rheumatol, Romberg syndrome, Sabre, Scleroderma, Sclerosis, Skin adnexa, Skin fibrosis, Skin lesion, Skin lesions, Subcutaneous, Subcutaneous tissue, Syndrome, Systemic, Systemic sclerosis, Tiny calcifications.
Abstract
Abstract: Localized scleroderma (LS), a rare disease that occurs primarily in the pediatric age group, differs from systemic sclerosis (SSc) in that it is usually limited to the skin and subcutaneous tissue and is only rarely associated with systemic manifestations. The authors' experience with pediatric LS seen in 30 patients at a tertiary care center was reviewed: 26 had linear scleroderma, 19 on an extremity and 7 on the face; 3 had morphea; and 1 had generalized morphea. Antinuclear antibodies were present in 76% and rheumatoid factor in 39%. Five of 19 patients with linear scleroderma that involved an extremity had growth failure in that limb, and 1 required surgery. Sclerodermatous involvement over a joint resulted in limited range of movement in 6 patients, and 1 required surgery. One of the 30 patients developed SSc and polymyositis. There was difficulty in evaluating disease activity and hence in evaluating treatment. This experience with a large patient population suggests that LS, although usually a self-limiting disease, can result in significant morbidity.
Url:
DOI: 10.1016/0049-0172(94)90028-0
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 002782
- to stream Istex, to step Curation: 002782
- to stream Istex, to step Checkpoint: 001A14
- to stream Main, to step Merge: 002C89
- to stream Main, to step Curation: 002C29
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title>Localized scleroderma in childhood: A report of 30 cases</title><author><name sortKey="Uziel, Yosef" sort="Uziel, Yosef" uniqKey="Uziel Y" first="Yosef" last="Uziel">Yosef Uziel</name></author><author><name sortKey="Krafchik, Bernice R" sort="Krafchik, Bernice R" uniqKey="Krafchik B" first="Bernice R." last="Krafchik">Bernice R. Krafchik</name></author><author><name sortKey="Silverman, Earl D" sort="Silverman, Earl D" uniqKey="Silverman E" first="Earl D." last="Silverman">Earl D. Silverman</name></author><author><name sortKey="Thorner, Paul S" sort="Thorner, Paul S" uniqKey="Thorner P" first="Paul S." last="Thorner">Paul S. Thorner</name></author><author><name sortKey="Laxer, Ronald M" sort="Laxer, Ronald M" uniqKey="Laxer R" first="Ronald M." last="Laxer">Ronald M. Laxer</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:516E15ABCB12A88E1B4DB6AE376A73629B74E6CF</idno><date when="1994" year="1994">1994</date><idno type="doi">10.1016/0049-0172(94)90028-0</idno><idno type="url">https://api.istex.fr/ark:/67375/6H6-S7Z8STZ9-R/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">002782</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">002782</idno><idno type="wicri:Area/Istex/Curation">002782</idno><idno type="wicri:Area/Istex/Checkpoint">001A14</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">001A14</idno><idno type="wicri:doubleKey">0049-0172:1994:Uziel Y:localized:scleroderma:in</idno><idno type="wicri:Area/Main/Merge">002C89</idno><idno type="wicri:Area/Main/Curation">002C29</idno><idno type="wicri:Area/Main/Exploration">002C29</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a">Localized scleroderma in childhood: A report of 30 cases</title><author><name sortKey="Uziel, Yosef" sort="Uziel, Yosef" uniqKey="Uziel Y" first="Yosef" last="Uziel">Yosef Uziel</name><affiliation wicri:level="1"><country xml:lang="fr">Canada</country><wicri:regionArea>Division of Rheumatology, The Hospital for Sick Children</wicri:regionArea><wicri:noRegion>The Hospital for Sick Children</wicri:noRegion></affiliation><affiliation wicri:level="4"><country xml:lang="fr">Canada</country><wicri:regionArea>1From the Divisions of Rheumatology and Dermatology, Department of Paediatrics, and the Department of Pathologe, The Hospital for Sick Children: und the Departments of Paediatrics, Immunology, Medicine, and Pathology, the University of Toronto, Toronto</wicri:regionArea><orgName type="university">Université de Toronto</orgName><placeName><settlement type="city">Toronto</settlement><region type="state">Ontario</region></placeName></affiliation></author><author><name sortKey="Krafchik, Bernice R" sort="Krafchik, Bernice R" uniqKey="Krafchik B" first="Bernice R." last="Krafchik">Bernice R. Krafchik</name><affiliation wicri:level="1"><country xml:lang="fr">Canada</country><wicri:regionArea>Division of Dermatology, The Hospital for Sick Children</wicri:regionArea><wicri:noRegion>The Hospital for Sick Children</wicri:noRegion></affiliation><affiliation wicri:level="4"><country xml:lang="fr">Canada</country><wicri:regionArea>1From the Divisions of Rheumatology and Dermatology, Department of Paediatrics, and the Department of Pathologe, The Hospital for Sick Children: und the Departments of Paediatrics, Immunology, Medicine, and Pathology, the University of Toronto, Toronto</wicri:regionArea><orgName type="university">Université de Toronto</orgName><placeName><settlement type="city">Toronto</settlement><region type="state">Ontario</region></placeName></affiliation></author><author><name sortKey="Silverman, Earl D" sort="Silverman, Earl D" uniqKey="Silverman E" first="Earl D." last="Silverman">Earl D. Silverman</name><affiliation wicri:level="1"><country xml:lang="fr">Canada</country><wicri:regionArea>Division of Rheumatology, The Hospital for Sick Children</wicri:regionArea><wicri:noRegion>The Hospital for Sick Children</wicri:noRegion></affiliation><affiliation></affiliation></author><author><name sortKey="Thorner, Paul S" sort="Thorner, Paul S" uniqKey="Thorner P" first="Paul S." last="Thorner">Paul S. Thorner</name><affiliation wicri:level="1"><country xml:lang="fr">Canada</country><wicri:regionArea>The Hospital for Sick Children</wicri:regionArea></affiliation><affiliation wicri:level="4"><country xml:lang="fr">Canada</country><wicri:regionArea>1From the Divisions of Rheumatology and Dermatology, Department of Paediatrics, and the Department of Pathologe, The Hospital for Sick Children: und the Departments of Paediatrics, Immunology, Medicine, and Pathology, the University of Toronto, Toronto</wicri:regionArea><orgName type="university">Université de Toronto</orgName><placeName><settlement type="city">Toronto</settlement><region type="state">Ontario</region></placeName></affiliation></author><author><name sortKey="Laxer, Ronald M" sort="Laxer, Ronald M" uniqKey="Laxer R" first="Ronald M." last="Laxer">Ronald M. Laxer</name><affiliation wicri:level="1"><country>Canada</country><wicri:regionArea>Address correspondence to Ronald M. Laxer, MD, Division of Rheumatology, The Hospital for Sick Children, 555 University Ave, Toronto, Ontario</wicri:regionArea><wicri:noRegion>Ontario</wicri:noRegion></affiliation><affiliation wicri:level="1"><country xml:lang="fr">Canada</country><wicri:regionArea>Head, Division of Rheumatology, The Hospital for Sick Children</wicri:regionArea><wicri:noRegion>The Hospital for Sick Children</wicri:noRegion></affiliation><affiliation wicri:level="4"><country xml:lang="fr">Canada</country><wicri:regionArea>1From the Divisions of Rheumatology and Dermatology, Department of Paediatrics, and the Department of Pathologe, The Hospital for Sick Children: und the Departments of Paediatrics, Immunology, Medicine, and Pathology, the University of Toronto, Toronto</wicri:regionArea><orgName type="university">Université de Toronto</orgName><placeName><settlement type="city">Toronto</settlement><region type="state">Ontario</region></placeName></affiliation></author></analytic><monogr></monogr><series><title level="j">Seminars in Arthritis and Rheumatism</title><title level="j" type="abbrev">YSARH</title><idno type="ISSN">0049-0172</idno><imprint><publisher>ELSEVIER</publisher><date type="published" when="1994">1994</date><biblScope unit="volume">23</biblScope><biblScope unit="issue">5</biblScope><biblScope unit="page" from="328">328</biblScope><biblScope unit="page" to="340">340</biblScope></imprint><idno type="ISSN">0049-0172</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0049-0172</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="Teeft" xml:lang="en"><term>Achilles tendon</term><term>Acta derm venereol</term><term>Active phase</term><term>Anticentromere antibodies</term><term>Antihistone antibodies</term><term>Antinuclear antibodies</term><term>Arch dermatol</term><term>Arthritis rheum</term><term>Cerebral calcification</term><term>Clinical evaluation</term><term>Clinical study</term><term>Collagen</term><term>Collagen fibers</term><term>Convulsive disorders</term><term>Coup</term><term>Crest syndrome</term><term>Degranulated mast cells</term><term>Dermatol</term><term>Disease activity</term><term>Erythrocyte sedimentation rate</term><term>Family history</term><term>Fibroblast</term><term>Fibroblast proliferation</term><term>Fibrotic</term><term>Frontal lobe</term><term>Generalized morphea</term><term>Growth factor</term><term>Growth failure</term><term>Intravenous immunoglobulin</term><term>Intravenous methylprednisolone</term><term>Laboratory results</term><term>Lesion</term><term>Limited range</term><term>Linear sclcroderma</term><term>Linear scleroderma</term><term>Localized</term><term>Localized cutaneous scleroderma</term><term>Localized scleroderma</term><term>Many patients</term><term>Mast cell activation</term><term>Mast cell tryptase</term><term>Mast cells</term><term>Maxillary antrum</term><term>Medical history</term><term>Morphea</term><term>Mouse model</term><term>Muscle atrophy</term><term>Neurological symptoms</term><term>Nsaid</term><term>Pediatric</term><term>Pediatric series</term><term>Penicillamine</term><term>Pigmentary changes</term><term>Plastic surgery</term><term>Rare disease</term><term>Rheum</term><term>Rheumatoid factor</term><term>Rheumatol</term><term>Romberg syndrome</term><term>Sabre</term><term>Scleroderma</term><term>Sclerosis</term><term>Skin adnexa</term><term>Skin fibrosis</term><term>Skin lesion</term><term>Skin lesions</term><term>Subcutaneous</term><term>Subcutaneous tissue</term><term>Syndrome</term><term>Systemic</term><term>Systemic sclerosis</term><term>Tiny calcifications</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Abstract: Localized scleroderma (LS), a rare disease that occurs primarily in the pediatric age group, differs from systemic sclerosis (SSc) in that it is usually limited to the skin and subcutaneous tissue and is only rarely associated with systemic manifestations. The authors' experience with pediatric LS seen in 30 patients at a tertiary care center was reviewed: 26 had linear scleroderma, 19 on an extremity and 7 on the face; 3 had morphea; and 1 had generalized morphea. Antinuclear antibodies were present in 76% and rheumatoid factor in 39%. Five of 19 patients with linear scleroderma that involved an extremity had growth failure in that limb, and 1 required surgery. Sclerodermatous involvement over a joint resulted in limited range of movement in 6 patients, and 1 required surgery. One of the 30 patients developed SSc and polymyositis. There was difficulty in evaluating disease activity and hence in evaluating treatment. This experience with a large patient population suggests that LS, although usually a self-limiting disease, can result in significant morbidity.</div></front></TEI><affiliations><list><country><li>Canada</li></country><region><li>Ontario</li></region><settlement><li>Toronto</li></settlement><orgName><li>Université de Toronto</li></orgName></list><tree><country name="Canada"><noRegion><name sortKey="Uziel, Yosef" sort="Uziel, Yosef" uniqKey="Uziel Y" first="Yosef" last="Uziel">Yosef Uziel</name></noRegion><name sortKey="Krafchik, Bernice R" sort="Krafchik, Bernice R" uniqKey="Krafchik B" first="Bernice R." last="Krafchik">Bernice R. Krafchik</name><name sortKey="Krafchik, Bernice R" sort="Krafchik, Bernice R" uniqKey="Krafchik B" first="Bernice R." last="Krafchik">Bernice R. Krafchik</name><name sortKey="Laxer, Ronald M" sort="Laxer, Ronald M" uniqKey="Laxer R" first="Ronald M." last="Laxer">Ronald M. Laxer</name><name sortKey="Laxer, Ronald M" sort="Laxer, Ronald M" uniqKey="Laxer R" first="Ronald M." last="Laxer">Ronald M. Laxer</name><name sortKey="Laxer, Ronald M" sort="Laxer, Ronald M" uniqKey="Laxer R" first="Ronald M." last="Laxer">Ronald M. Laxer</name><name sortKey="Silverman, Earl D" sort="Silverman, Earl D" uniqKey="Silverman E" first="Earl D." last="Silverman">Earl D. Silverman</name><name sortKey="Thorner, Paul S" sort="Thorner, Paul S" uniqKey="Thorner P" first="Paul S." last="Thorner">Paul S. Thorner</name><name sortKey="Thorner, Paul S" sort="Thorner, Paul S" uniqKey="Thorner P" first="Paul S." last="Thorner">Paul S. Thorner</name><name sortKey="Uziel, Yosef" sort="Uziel, Yosef" uniqKey="Uziel Y" first="Yosef" last="Uziel">Yosef Uziel</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002C29 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002C29 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= ChloroquineV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:516E15ABCB12A88E1B4DB6AE376A73629B74E6CF
|texte= Localized scleroderma in childhood: A report of 30 cases
}}
| This area was generated with Dilib version V0.6.33. |  |